SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-16
👔
ADIAL PHARMACEUTICALS, INC.
@ADIL_InsiderForm 4 Filing: Young Wendy B. Buys shares of $ADIL
INSIDER PURCHASE
⚡ MATERIALITY: 4/10
corporate issuer
ADIAL PHARMACEUTICALS, INC.
Ticker: $ADIL
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-12
Shares: 36,378
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Young Wendy B., holds the title of Director at ADIAL PHARMACEUTICALS, INC..
On 2026-06-12, the insider transacted 36,378 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Young Wendy B. (Director) bought $0 of $ADIL
Post-Transaction Position: 36,378 shares
SEC Accession No: 0001213900-26-069021 (CIK: 2042847)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.